Lung CT density correlates with measurements of airflow limitation and the diffusing capacity

We studied 80 subjects (63 M, 17 F; 23-82 yrs) and related lung computerized tomography (CT) density with age, height, spirometry, lung volumes, diffusing capacity and arterial blood gas tensions. These subjects demonstrated a wide range of physiological impairment (forced expiratory volume in one second (FEV1) 8-116% predicted; diffusing capacity (Kco) 15-139% predicted; arterial oxygen tension (Pao2) 38-91 mmHg). They ranged from normal subjects to patients with chronic respiratory failure. Lung density was derived from CT density histograms measured as both mean Emergency Medical Information (EMI) number (EMI scale: 0 = water, -500 = air, EMI number of normal lung tissue range approximately -200 to -450) and the lowest 5th percentile EMI number, the latter value being more likely to represent the density of lung parenchyma. Lung CT density correlated most strongly with airflow obstruction (EMI 5th percentile versus FEV1/forced vital capacity (FVC) % predicted, r = 0.73, p less than 0.001) and diffusing capacity (EMI 5th percentile versus Kco, r = 0.77, p less than 0.001). This suggests that reduction in lung density, which reflects loss of the surface area of the distal airspaces, is a major index of respiratory function in patients with smoking related chronic obstructive pulmonary disease (COPD). These data provide no indication of other factors such as small and large airways disease, and loss of elastic recoil, which may contribute to airflow limitation, or disruption of the pulmonary vascular bed which may also affect CT lung density.

This article has been cited by other articles:

				G. E. Silva, S. Guerra, S. Keim, R. A. Barbee, and D. L. Sherrill Longitudinal Decline of Diffusing Capacity of the Lung for Carbon Monoxide in Community Subjects With the PiMZ {alpha}1-Antitrypsin Phenotype Chest, May 1, 2008; 133(5): 1095 - 1100. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				H. Makita, Y. Nasuhara, K. Nagai, Y. Ito, M. Hasegawa, T. Betsuyaku, Y. Onodera, N. Hizawa, M. Nishimura, and the Hokkaido COPD Cohort Study Group Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease Thorax, November 1, 2007; 62(11): 932 - 937. [Abstract] [Full Text] [PDF]

				Z. A. Aziz, A. U. Wells, S. R. Desai, S. M. Ellis, A. E. Walker, S. MacDonald, and D. M. Hansell Functional Impairment in Emphysema: Contribution of Airway Abnormalities and Distribution of Parenchymal Disease Am. J. Roentgenol., December 1, 2005; 185(6): 1509 - 1515. [Abstract] [Full Text] [PDF]

				N. MacIntyre, R. O. Crapo, G. Viegi, D. C. Johnson, C. P. M. van der Grinten, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, P. Enright, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur. Respir. J., October 1, 2005; 26(4): 720 - 735. [Abstract] [Full Text] [PDF]

				S B Shaker, T Stavngaard, J Stolk, B Stoel, and A Dirksen {alpha}1-Antitrypsin deficiency {middle dot} 7: Computed tomographic imaging in {alpha}1-antitrypsin deficiency Thorax, November 1, 2004; 59(11): 986 - 991. [Abstract] [Full Text] [PDF]

				M. M. Marc, P. Korosec, M. Kosnik, I. Kern, M. Flezar, S. Suskovic, and J. Sorli Complement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 216 - 219. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF]

				J. Reid and D. Cockcroft Severe Centrilobular Emphysema in a Patient Without Airflow Obstruction Chest, January 1, 2002; 121(1): 307 - 308. [Full Text] [PDF]

				F Mitsunobu, T Mifune, K Ashida, Y Hosaki, H Tsugeno, M Okamoto, S Harada, S Takata, and Y Tanizaki Influence of age and disease severity on high resolution CT lung densitometry in asthma Thorax, November 1, 2001; 56(11): 851 - 856. [Abstract] [Full Text] [PDF]

				S. C. McCLOSKEY, B. D. PATEL, S. J. HINCHLIFFE, E. D. REID, N. J. WAREHAM, and D. A. LOMAS Siblings of Patients With Severe Chronic Obstructive Pulmonary Disease Have a Significant Risk of Airflow Obstruction Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1419 - 1424. [Abstract] [Full Text] [PDF]

				L.J. Dowson, P.J. Guest, S.L. Hill, R.L. Holder, and R.A. Stockley High-resolution computed tomography scanning in {alpha}1-antitrypsin deficiency: relationship to lung function and health status Eur. Respir. J., June 1, 2001; 17(6): 1097 - 1104. [Abstract] [Full Text] [PDF]

				J.M.B. Hughes and N.B. Pride In defence of the carbon monoxide transfer coefficient KCO (TL/VA) Eur. Respir. J., February 1, 2001; 17(2): 168 - 174. [Abstract] [Full Text] [PDF]

				G. T. Ferguson, P. L. Enright, A. S. Buist, and M. W. Higgins Office Spirometry for Lung Health Assessment in Adults: A Consensus Statement From the National Lung Health Education Program Chest, April 1, 2000; 117(4): 1146 - 1161. [Abstract] [Full Text] [PDF]

				D. L. SHERRILL, P. L. ENRIGHT, W. T. KALTENBORN, and M. D. LEBOWITZ Predictors of Longitudinal Change in Diffusing Capacity over 8 Years Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1883 - 1887. [Abstract] [Full Text]